WOCKHARDT BIO AG FDA Approval ANDA 040420

ANDA 040420

WOCKHARDT BIO AG

FDA Drug Application

Application #040420

Documents

Letter2003-04-09
Review2006-04-20

Application Sponsors

ANDA 040420WOCKHARDT BIO AG

Marketing Status

Prescription001

Application Products

001SUSPENSION;ORAL125MG/5ML0PHENYTOINPHENYTOIN

FDA Submissions

ORIG1AP2002-04-19
LABELING; LabelingSUPPL2AP2002-11-06
MANUF (CMC); Manufacturing (CMC)SUPPL3AP2002-11-06
LABELING; LabelingSUPPL4AP2003-12-09
LABELING; LabelingSUPPL5AP2005-04-20
LABELING; LabelingSUPPL9AP2010-02-02

Submissions Property Types

SUPPL1Null0
SUPPL3Null0
SUPPL9Null7

TE Codes

001PrescriptionAB

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 40420
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.